Influenza-associated cardiovascular mortality in older adults in Beijing, China: a population-based time-series study

Objective This study comprehensively estimated the excess cardiovascular disease (CVD) mortality attributable to influenza in an older (age ≥65 years) population. Design Ecological study. Setting Aggregated data from administrative systems on CVD mortality, influenza surveillance and meteorological data in Beijing, China. Main outcome measure Excess overall CVD, and separately for ischaemic heart disease (IHD), ischaemic stroke, haemorrhagic stroke mortality attributable to influenza, adjusting for influenza activity, time trend, seasonality and ambient temperature. Results CVD (risk ratio (RR) 1.02, 95% CI 1.01, 1.02), IHD (RR 1.01, 95% CI 1.01, 1.02), ischaemic stroke (RR=1.03, 95% CI 1.02, 1.04), but not haemorrhagic stroke (RR=1.00, 95% CI 0.99, 1.01) mortality, were significantly associated with every 10% increase in influenza activity. An increase in circulating A(H1N1)09pdm, A(H3N2) and B type virus were all significantly associated with CVD and ischaemic stroke mortality, but only A(H3N2) and B type virus with IHD mortality. The strongest increase in disease mortality was in the same week as the increase in influenza activity. Annual excess CVD mortality rate attributable to influenza ranged from 54 to 96 per 100 000 population. The 3%–6% CVD mortality attributable to influenza activity was related to an annual excess of 916–1640 CVD deaths in Beijing, China. Conclusions Influenza activity has moderate to strong associations with CVD, IHD and ischaemic stroke mortality in older adults in China. Promoting influenza vaccination could have major health benefit in this population. Background Influenza may trigger serious CVD events. An estimation of excess CVD mortality attributable to influenza has particular relevance in China where vaccination is low and CVD burden is high. Methods This study analysed data at the population level (age ≥65 years) using linked aggregated data from administrative systems on CVD mortality, influenza surveillance and meteorological data during 2011 to 2018. Quasi-Poisson regression models were used to estimate the excess overall CVD, and separately for IHD, ischaemic stroke, haemorrhagic stroke mortality attributable to influenza, adjusting for influenza activity, time trend, seasonality and ambient temperature. Analyses were also undertaken for influenza subtypes (A(H1N1)09pdm, A(H3N2) and B viruses), and mortality risk with time lags of 1–5 weeks following influenza activity in the current week.

[1]  M. Wong,et al.  Ambient temperature, seasonal influenza and risk of cardiovascular disease in a subtropical area in Southern China. , 2020, Environmental research.

[2]  S. Li,et al.  [The mortality burden of influenza in China: a systematic review]. , 2019, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[3]  Shiwei Liu,et al.  Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. , 2019, The Lancet. Public health.

[4]  F. Zhu,et al.  Influenza surveillance in China: a big jump, but further to go. , 2019, The Lancet. Public health.

[5]  C. Anderson,et al.  Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement: JACC International. , 2019, Journal of the American College of Cardiology.

[6]  Dayan Wang,et al.  A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004–2014 , 2019, BMC Public Health.

[7]  S. Solomon,et al.  Influenza Vaccine in Heart Failure: Cumulative Number of Vaccinations, Frequency, Timing, and Survival A Danish Nationwide Cohort Study , 2019, Circulation.

[8]  S. Solomon,et al.  Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. , 2018, JACC. Heart failure.

[9]  J. Ferreira,et al.  Influenza vaccination and prevention of cardiovascular disease mortality , 2018, The Lancet.

[10]  J. Cacioppo,et al.  The growing problem of loneliness , 2018, The Lancet.

[11]  Jan Kyncl,et al.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.

[12]  A. Iuliano,et al.  Mortality burden from seasonal influenza and 2009 H1N1 pandemic influenza in Beijing, China, 2007‐2013 , 2017, Influenza and other respiratory viruses.

[13]  Ming-Hsien Chiang,et al.  Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients , 2017, American heart journal.

[14]  S. E. Jensen,et al.  Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial. , 2017, American heart journal.

[15]  Xiling Wang,et al.  Excess mortality associated with influenza after the 2009 H1N1 pandemic in a subtropical city in China, 2010-2015. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[16]  Adrian F. Hernandez,et al.  Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions. , 2017, JACC. Heart failure.

[17]  B. Cowling,et al.  Edinburgh Research Explorer Seasonal influenza vaccination in China , 2022 .

[18]  Kazuhiko Ito,et al.  Seasonal Influenza Infections and Cardiovascular Disease Mortality. , 2016, JAMA cardiology.

[19]  Peng Yin,et al.  An integrated national mortality surveillance system for death registration and mortality surveillance, China , 2015, Bulletin of the World Health Organization.

[20]  C. Clar,et al.  Influenza vaccines for preventing cardiovascular disease. , 2015, The Cochrane database of systematic reviews.

[21]  Bryan R. Smith,et al.  Infectious causes of stroke. , 2014, The Lancet. Infectious diseases.

[22]  Chun-Yuh Yang,et al.  Association of Influenza Vaccination and Reduced Risk of Stroke Hospitalization among the Elderly: A Population-Based Case-Control Study , 2014, International journal of environmental research and public health.

[23]  Peng Wu,et al.  Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. , 2012, The Journal of infectious diseases.

[24]  Cecile Viboud,et al.  Improving the Estimation of Influenza-Related Mortality Over a Seasonal Baseline , 2012, Epidemiology.

[25]  Weizhong Yang,et al.  Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. , 2012, Bulletin of the World Health Organization.

[26]  S. Khurana,et al.  Influenza Virus H1N1pdm09 Infections in the Young and Old: Evidence of Greater Antibody Diversity and Affinity for the Hemagglutinin Globular Head Domain (HA1 Domain) in the Elderly than in Young Adults and Children , 2012, Journal of Virology.

[27]  J. Martínez-Rodríguez,et al.  Previous Infection and Stroke: A Prospective Study , 2012, Cerebrovascular Diseases.

[28]  Quanyi Wang,et al.  Review of an Influenza Surveillance System, Beijing, People’s Republic of China , 2009, Emerging infectious diseases.

[29]  P. Heuschmann,et al.  Temporal relationship between influenza infections and subsequent first-ever stroke incidence. , 2008, Age and ageing.

[30]  N. Ferguson,et al.  Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.

[31]  H. Krumholz,et al.  Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. , 2006, Journal of the American College of Cardiology.

[32]  A. Grau,et al.  Influenza Vaccination Is Associated With a Reduced Risk of Stroke , 2005, Stroke.

[33]  A. Hedley,et al.  Influenza-associated mortality in Hong Kong. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  M. Naghavi,et al.  Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. , 2003, Circulation.

[35]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.